3Whithaus K, Fukuoka J, Prihoda TJ, et al. Evaluation of napsin A, CK5/6, p63 and TFF - 1 in adenocarcinoma versus squamous cell carcinoma of the lung[ J]. Arch Pathol Lab Med,2012,136 (2) :155 -162.
4Hong E K. The Cytopathology of body cavity fluid [ J ]. Korean J Cytopathol, 2008,19(2) :72 -85.
5Ensani F, Nematizadeh F, Irvanlou G. Accuracy of immunohisto- chemistry in evaluation of malignant pleural and peritoneal effu- sions[ J]. Pol J Pathol, 2011,62(2) :95 - 100.
6Bassarova A V, Nesland J M, Davidson B. D2 -40 is not a spe- cific marker for cells of mesothelial origin in serous effusions [ J ]. Am J Surg Pathol, 2006,30(7) :878 -82.
7Sayed D M, el-Attar M M, Hussein A A. Evaluation of flow cyto- metric immunophenotyping and DNA analysis for detection of ma- lignant cells in serosal cavity fluids[J]. Diagn Cytopathol, 2009, 37(7) :498 -504.
8Davidson B. Malignant effusions: from diagnosis to biology [ J ]. Diagn Cytopathol, 2004,31 (4) :246 - 54.
9Thapar M, Mishra R K, Sharma A, Critical analysis of cell block versus smear examination in effusions[ J]. J Cytol, 2009,26 ( 2 ) : 60 - 4.
10Bigras G, Rieder M A, Lambercy J M, et al. Keeping Collecting device in liquid mediem is mandatory to ensure optimized liquid- based cervical cytologic sampling [ J ]. J Low Genit Tract Dis, 2003,7(3) :168 -74.
